| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Dec 8, 2025 | XOMA Royalty Corp | CEO | Buy | 100.0 | +100,000 | 99.44% | ✗ | $2.5M |
| May 19, 2025 | May 21, 2025 | XOMA Royalty Corp | CEO | Sell | 40.0 | -25,637 | -28.29% | ✗ | $650.7K |
| Nov 11, 2024 | Nov 13, 2024 | XOMA Royalty Corp | CEO | Sell | 40.0 | -21,881 | -37.17% | ✗ | $655.3K |
| Oct 2, 2023 | Oct 4, 2023 | XOMA Royalty Corp | CEO | Buy | 91.3 | +1,000 | 22.22% | ✗ | $13.8K |
| Sep 25, 2023 | Sep 27, 2023 | XOMA Royalty Corp | CEO | Buy | 91.3 | +2,500 | 125.00% | ✗ | $36.1K |
| May 23, 2023 | May 25, 2023 | XOMA Royalty Corp | CEO | Buy | 91.3 | +2,000 | 100.00% | ✗ | $47.3K |
| Jan 12, 2021 | Jan 14, 2021 | Cullinan Therapeutics, Inc. | CEO | Buy | 65.0 | +2,500 | 0.50% | ✗ | $52.5K |